Amazon under the microscope. As restrictions kick in again this edition of Shares looks at one of the big lockdown winners and whether it can maintain its momentum.

Also insight into an historic US election, the impact that paying off debt can have on a stock and the pharmaceutical firm which has been left behind by its peers in 2020.

Also in the digital magazine: why cash is king when analysing a business, M&A action in the biotech space, how popular fund Fidelity Global Special Situations is sticking with the value theme, plus the collapse of Ant Group’s mega IPO in China and the implications for former parent Alibaba.